SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 409 filers reported holding SHOCKWAVE MED INC in Q4 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,993,199 | +100.5% | 140,598 | +187.4% | 0.03% | +106.2% |
| Q2 2023 | $13,961,686 | +146.2% | 48,918 | +87.1% | 0.02% | +128.6% |
| Q1 2023 | $5,670,321 | -68.4% | 26,151 | -70.0% | 0.01% | -66.7% |
| Q4 2022 | $17,929,158 | -52.0% | 87,193 | -35.1% | 0.02% | -56.2% |
| Q3 2022 | $37,338,000 | +71.0% | 134,275 | +17.5% | 0.05% | +77.8% |
| Q2 2022 | $21,841,000 | +178.3% | 114,251 | +201.9% | 0.03% | +237.5% |
| Q1 2022 | $7,847,000 | -29.7% | 37,840 | -39.6% | 0.01% | -27.3% |
| Q4 2021 | $11,164,000 | -18.8% | 62,602 | -6.3% | 0.01% | -26.7% |
| Q3 2021 | $13,753,000 | +9.1% | 66,803 | +0.5% | 0.02% | +7.1% |
| Q2 2021 | $12,610,000 | +93.8% | 66,465 | +33.0% | 0.01% | +75.0% |
| Q1 2021 | $6,508,000 | +67.3% | 49,959 | +33.2% | 0.01% | +60.0% |
| Q4 2020 | $3,889,000 | +52.9% | 37,496 | +11.7% | 0.01% | +25.0% |
| Q3 2020 | $2,544,000 | -0.6% | 33,563 | -37.9% | 0.00% | 0.0% |
| Q2 2020 | $2,560,000 | – | 54,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |